Galloway group reports 8.42% stake in WW
Galloway Capital Partners, Galloway Capital LP and Bruce Galloway filed a Schedule 13D disclosing beneficial ownership of 841,700 shares of WW International common stock, representing 8.42% of the company’s outstanding shares as of April 20, 2026.
Rhea-AI Filing Summary
Galloway Capital Partners, Galloway Capital LP and Bruce Galloway filed a Schedule 13D disclosing beneficial ownership of 841,700 shares of WW International common stock, representing 8.42% of the company’s outstanding shares as of April 20, 2026.
The position includes 378,700 shares of common stock and 463,000 shares underlying call options exercisable within 60 days. Galloway Capital Partners acquired 234,800 shares in open market purchases from March through May 2026 at an aggregate purchase price of about $12.26 per share, and the reporting persons bought call options for a total of $569,490.
The group states that the investment is for investment purposes but indicates it will continuously review its position and may buy more, hold, or sell shares. They also signal potential engagement with WW’s board and management on strategy, operations, governance and capital allocation, and have already sent a letter to management dated May 13, 2026.
Positive
- None.
Negative
- None.
Insights
Galloway reports an 8.42% WW stake and signals active engagement intentions.
Galloway Capital Partners, Galloway Capital LP and Bruce Galloway now report beneficial ownership of 841,700 WW International shares, or 8.42% of the common stock based on April 20, 2026 figures. The stake combines 378,700 shares and 463,000 shares underlying call options exercisable within 60 days.
The filing shows recent accumulation: 234,800 shares were bought in open market purchases from March 2026 through May 2026 at about $12.26 per share, plus 463,000 call-option shares purchased for $569,490. This scale positions the group as a significant shareholder with both equity and derivative exposure.
The purpose section states the investment is for investment purposes but explicitly contemplates ongoing review and potential changes in stake size, as well as engagement with the board and management on performance, governance, strategy and capital allocation. A letter to management dated May 13, 2026 is referenced, suggesting an organized dialogue that could influence future corporate decisions depending on how interactions evolve.
Key Figures
Key Terms
Schedule 13D regulatory
beneficially owned financial
call options financial
open market purchases financial
dispositive power financial
investment manager financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in WW (WW) does Galloway Capital report in this Schedule 13D?
How is Galloway Capital’s 8.42% WW (WW) position structured?
What are Galloway Capital’s stated intentions regarding its WW (WW) investment?
Did Galloway Capital communicate with WW (WW) management in connection with this 13D?
Who are the reporting persons in the WW (WW) Schedule 13D filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.